Acute decompensated heart failure (ADHF) in pediatrics is a significant cause for morbidity and mortality in children. Congenital heart disease and cardiomyopathy are the leading etiologies of ADHF. It is common for these children to undergo diagnostic, therapeutic, or surgical procedure under anesthesia, which may be associated with significant morbidity and mortality. The importance of preanesthetic multidisciplinary planning with all involved teams, including anesthesia, cardiology, intensive care, perfusion, and cardiac surgery, cannot be emphasized enough. In order to safely manage these patients, it is imperative for the anesthesiologist to understand the complex pathophysiological interactions between cardiopulmonary systems and anesthesia during these procedures. This review discusses the etiology, pathophysiology, clinical manifestations, and perioperative management of these patients.
HsuDTPearsonGD. Heart failure in children. part I: history, etiology, and pathophysiology. Circ. Heart Fail. 2009;2:63-70.
2.
MarinoBSTabbuttS, et. al. American heart association congenital cardiac defects committee of the council on cardiovascular disease in the young; council on clinical cardiology; council on cardiovascular and stroke Nursing; council on cardiovascular surgery and anesthesia; and emergency cardiopulmonary resuscitation in infants and children with cardiac disease: A scientific statement from the american heart association cardiovascular care committee. Circulation. 2018;137(22):e691-e782.
3.
Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed.Little Brown & Co.; 1994.
4.
RossRDBollingerROPinskyWW. Grading the severity of congestive heart failure in infants. Pediatr Cardiol. 1992;13:72-75.
5.
KirkRDipchandAIRosenthalDNAddonizioLBurchMChrisantM, et al. The international Society of Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: Executive summary. J Heart Lung Transplant. 2014;33:888-909.
6.
ChenSDykesJCMcElhinneyDB, et. al. Haemodynamic profiles of children with end-stage heart failure. Eur Heart J. 2017;38(38):2900-2909.
7.
FrankelDSVasanRSD’AgostinoRB, et. alResistin, adiponectin, and risk of heart failure. J Am Coll Cardiol. 2009;53:754-762.
8.
DamascenoAMayosiBMSaniM, et. alThe causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch Intern Med. 2012;172:1386-1394.
9.
RossanoJWShaddyRE. Heart failure in children: etiology and treatment. J Pediatr. 2014;165:228-233.
10.
DasBB. Current State of Pediatric Heart Failure. Children. 2018;5(7):88. doi:10.3390/children5070088.
11.
RossanoJWKimJJDeckerJA, et. alPrevalence, morbidity, and mortality of heart failure-related hospitalizations in children in the United States: a population-based study. J Card Fail. 2012;18:459-470.
12.
LasaJJGaiesMBushL, et. al. Epidemiology and Outcomes of Acute Decompensated Heart Failure in Children. Circ Heart Fail. 2020;13(4).
13.
WilkinsonJDLandyDCColanSD, et. alThe pediatric cardio- myopathy registry and heart failure: key results from the first 15 Years. Heart Fail Clin. 2010;6:401-413.
14.
SannaGSerrauGBassareoPPNeroniPFanosVMarcialisMA. Children's heart and COVID-19: Up-to-date evidence in the form of a systematic review. Eur J Pediatr. 2020;179(7):1079-1087. doi:10.1007/s00431-020-03699-0.
FedermannMHessOM. Differentiation between systolic and diastolic dysfunction. Eur Heart J. 1994 Dec;15(suppl D):2-6. doi:10.1093/eurheartj/15.suppl_d.2.
17.
BraunwaldEBristowMR. Congestive heart failure: fifty years of progress. Circulation. 2000;102(4):IV14-23.
18.
MunizRTMesquitaETSouza JuniorCVMartinsWA. Pulmonary ultrasound in patients with heart failure - Systematic Review. Arq Bras Cardiol. 2018;110(6):577-584.
19.
ChengodeS. Left ventricular global systolic function assessment by echocardiography. Ann Card Anaesth. 2016;19(suppl ment):S26-S34.
20.
FeltesTFBachaEBeekmanRH, et. alIndications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Circulation. 2011;123(22):2607-2652.
21.
KirkRDipchandAIRosenthalDN, et. alThe international society for heart lung transplantation guidelines for the management of pediatric heart failure: executive summary. J Heart Lung Transplant. 2014;33(9):888-909.
22.
DomicoMAllenM. Biomarkers in pediatric critical care. Pediatr Crit Care. 2016;17:S215-S221.
23.
KochAZinkSSingerH. B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J. 2006;27:861-866.
24.
MedarSSHsuDTUshayHMLamourJMCohenHWKillingerJS. Serial measurement of amino-terminal pro-B natriuretic peptide predicts adverse cardiovascular outcome in children with primary myocardial dysfunction and acute decompensated heart failure. Pediatr Crit Care Med. 2015;16:529-534.
25.
TakaseHDohiY. Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship. Eur J Clin Invest. 2014;44(3):303-308.
26.
DaubeneyPEPilkingtonSNJankeECharltonGASmithDCWebberSA. Cerebral oxygenation measured by near-infrared spectroscopy: comparison with jugular bulb oximetry. Ann Thorac Surg. 1996;61(3):930-934.
27.
YoxallCWWeindlingAMDawaniNHPeartI. Measurement of cerebral venous oxyhemoglobin saturation in children by near-infrared spectroscopy and partial jugular venous occlusion. Pediatr Res. 1995;38(3):319-323.
28.
RamamoorthyCHaberkernCMBhanankerSM, et. al. Anesthesia-related cardiac arrest in children with heart disease: data from the pediatric perioperative cardiac arrest (POCA) registry. Anesth Analg. 2010;110(5):1376-1382.
29.
FaraoniDZurakowskiDVoD, et. al. Post-Operative Outcomes in Children With and Without Congenital Heart Disease Undergoing Noncardiac Surgery. J Am Coll Cardiol. 2016;67(7):793-801.
30.
MurphyTWSmithJHRangerMRHaynesSR. General anesthesia for children with severe heart failure. Pediatr Cardiol. 2011;32(2):139-144.
31.
KippsAKRamamoorthyCRosenthalDNWilliamsGD. Children with cardiomyopathy: complications after noncardiac procedures with general anesthesia. Paediatr Anaesth. 2007;17(8):775-781.
32.
LynchJPehoraCHoltbyHSchwarzSMTaylorK. Cardiac arrest upon induction of anesthesia in children with cardiomyopathy: an analysis of incidence and risk factors. Paediatr Anaesth. 2011;21(9):951-957.
33.
BrierleyJCarcilloJAChoongK, et. al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crt Care Med. 2009;37(2):666-688.
34.
SingRChoudhuryMKapoorPMKiranU. A randomized trial of anesthetic induction agents in patients with coronary artery disease and left ventricular dysfunction. Ann Card Anaesth. 2010;13.
35.
PhillipsAMcMurrayTJMirakhurRKGibsonFMElliotP. Propofol-fentanyl anaesthesia in cardiac surgery: comparison in patients with good and impaired ventricular function. Anaesthesia. 1993;48:661-663.
36.
Hemodynamic Responses to Etomidate Versus Ketamine-Thiopental Sodium Combination for Anesthetic Induction in Coronary Artery Bypass Graft Surgery Patients with Low Ejection Fraction: A Double-Blind, Randomized, Clinical Trial. J Clin Diagn Res. 2014, Vol-8(10): GC01-GC05.
37.
SarkarMLaussenPCZurakowskiDShuklaAKussmanBOdegardKC. Hemodynamic response to etomidate on induction of anesthesia in pediatric patients. Anesth Analg. 2005;101(3):645-650.
38.
RivenesSMLewinMBStayerSA, et. alCardiovascular effects of sevoflurane, isoflurane, halothane, and fentanyl-midazolam in children with congenital heart disease: an echocardiographic study of myocardial contractility and hemodynamics. Anesthesiology. 2001;94:223.
39.
YukiKLeeSStaffaSDiNardoJ. Induction techniques for pediatric patients with congenital heart disease undergoing noncardiac procedures are influenced by cardiac functional status and residual lesion burden. J Clin Anesth. 2018;50:14-17.
40.
AlviarCLMillerPEMcAreaveyD, et. alPositive Pressure Ventilation in the Cardiac Intensive Care Unit. J Am Coll Cardiol. 2018;72(13):1532-1553.
41.
RevesanestheticsJGIMillerRDErikssonLIFleisherLAWiener-KronishPJYoungLA. Miller Anesthesia. 7th ed.Churchill Livingstone; 2010:P728-P734.
42.
HickeyPRHansenDHCramoliniGMVincentRNLangP. Pulmonary and systemic hemodynamic responses to ketamine in infants with normal and elevated pulmonary vascular resistance. Anesthesiology. 1985;62:287-293.
43.
SchechterWSKimCMartinezMGleasonBFLundDPBurrowsFA. Anaesthetic induction in a child with end-stage cardiomyopathy. Can J Anaesth. 1995;42(5 Pt 1):404-408.
44.
DewhirstEFrazierWJLederMFraserDDTobiasJD. Cardiac arrest following ketamine administration for rapid sequence intubation. J Intensive Care Med. 2013;28(6):375-379.
45.
SprungJSchuetzSMStewartRWMoravecCS. Effects of ketamine on the contractility of failing and nonfailing human heart muscles in vitro. Anesthesiology. 1998;88(5):1202-1210.
46.
GelissenHPEpemaAHHenningRHKrijnenHJHennisPJden HertogA. Inotropic effects of propofol, thiopental, midazolam, etomidate, and ketamine on isolated human atrial muscle. Anesthesiology. 1996;84:397-403.
47.
ZhengDUptonRNMartinezAM. The contribution of the coronary concentrations of propofol to its cardiovascular effects in anesthetized sheep. Anesth Analg. 2003;96:1589-1597.
48.
LoweDHettrickDouglasAWarltierDC. Propofol alters left ventricular afterload as evaluated by aortic input impedance in dogs. Anesthesiology. 1996;84:368-376.
49.
IkembaCMSuJTStayerSAMiller-HanceWCEidemBWBezoldLI, et alMyocardial performance index with sevoflurane- pancuronium versus fentanyl-midazolam-pancuronium in infants with a functional single ventricle. Anesthesiology. 2004;101(6):1298-1305.
50.
van den BrinkFSMeijersTAHofmaSH, et. alProphylactic veno-arterial extracorporeal membrane oxygenation in patients undergoing high-risk percutaneous coronary intervention. Neth Heart J. 2020;28(3):139-144.
51.
PetrozGCSikichNJamesM, et. alA phase I, two center study of the pharmacokinetics and pharmacodynamicsof dexmedetomidine in children. Anesthesiology. 2006;105:1098-1110.
52.
BronickiRAPennyDJAnasNGFuhrmanB. Cardiopulmonary Interactions. Pediatr Crit Care Med. 2016;17(8 suppl 1):S182-S193.
53.
YangXDuB. Does pulse pressure variation predict fluid responsiveness in critically ill patients? A systematic review and meta-analysis. Crit Care. 2014;18(6):650.
54.
FaraoniDMeierJNewHVVan der LindenPJHuntBJ. Patient Blood Management for Neonates and Children Undergoing Cardiac Surgery: 2019 NATA Guidelines. J Cardiothorac Vasc Anesth. 2019;33(12):3249-3263.
55.
GreenwayCV. Mechanism and quantitative assessment of drug effects on cardiac output with a new model of circulation. Pharmacol Rev. 1981;33:213-251.
56.
TumeSCSchwartzSMBronickiRA. Pediatric cardiac intensive care society 2014 consensus statement: pharmacotherapies in cardiac critical care treatment of acute heart failure. Pediatr Crit Care Med. 2016;17(3 suppl 1):S16-S19.
57.
AmietVPerezMHLongchampD, et. alUse of levosimendan in postoperastive setting after cardiac surgical repair of congenital heart disease in children. Pediatr cardiol. 2018;39:19-25.
58.
RheeEKCanterCEBasileSWebberSANaftelDC. Sudden death prior to pediatric heart transplantation: would implantable defibrillators improve outcome?J Heat Lung Transplant. 2007;26:447.
59.
NagpalADSingalRKAroraRCLamarcheY. Temporary mechanical circulatory support in cardiac critical care: a state of the art review and algorithm for device selection. Can J Cardiol. 2017;33(1):110-118.
60.
ZaleskiKLSchollRLThiagarajanRR, et. alElective extracorporeal membrane oxygenation support for high-Risk pediatric cardiac catheterization. J Cardiothorac Vasc Anesth. 2019;33(7):1932-1938.
61.
DimasVVMorrayBHKimDW, et. alA multicenter study of the impella device for mechanical support of the systemic circulation in pediatric and adolescent patients. Cathet Cardiovasc Interv. 2017;90(1):124-129.
62.
ParekhDJeewaATumeSC, et. alPercutaneous mechanical circulatory support using impella devices for decompensated cardiogenic shock: a pediatric heart center experience. Am Soc Artif Intern Organs J. 2018;64(1):98-104.
63.
MorrayBHDimasVVLimS, et. alCirculatory support using the impella device in fontan patients with systemic ventricular dysfunction: a multicenter experience. Cathet Cardiovasc Interv. 2017;90(1):118-123.
64.
ShughSBRiggsKWMoralesDLS. Mechanical circulatory support in children: past, present and future. Transl Pediatr. 2019;8(4):269-277. doi:10.21037/tp.2019.07.14.
